{"id":169537,"date":"2025-10-26T22:11:44","date_gmt":"2025-10-26T22:11:44","guid":{"rendered":"https:\/\/quixnet.net\/wpinstance\/novartis-to-acquire-avidity-biosciences-for-about-12-billion-reuters\/"},"modified":"2025-10-26T22:11:44","modified_gmt":"2025-10-26T22:11:44","slug":"novartis-to-acquire-avidity-biosciences-for-about-12-billion-reuters","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/novartis-to-acquire-avidity-biosciences-for-about-12-billion-reuters\/","title":{"rendered":"Novartis to acquire Avidity Biosciences for about $12 billion &#8211; Reuters"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiuwFBVV95cUxQVHdwZjZBdkpiT18wdlh4V3FHTEcxVmp4OGJ3cmZfLVhoa015ZjJwTEpEZC1fb09JLTlPVUlBR0ZoVFFWanVmLTNNdVJCR29qUUdEeVFaUlVNS3ZkZEtmeURlZF9FTG5JQkVhLTMzdXRNN0ZYeHFrYllyQkdUa1dNT0pwbFlDRGdmVnNlUjctUVNIV1dGTTdfb1FTWWhweTJiRElJdF9pajJEVDhySEgzZEZXVDlqVVlJTWhN?oc=5\" target=\"_blank\">Novartis to acquire Avidity Biosciences for about $12 billion<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMie0FVX3lxTE5aM2J3elR2QkxVV2xrTEdLNFV2NUk4ZTA3bDJwTkRXdlJxVld6YkFkRTBwQk9IVzdNLXdtWEl6VjN3R3FjcnYxdVJxcnd2NXEwTnktd0NIOVpKRDJvQ0RzYVNGU0c1YWtLN1JVRW5kOUE0Sl9FRzRZcDQyZ9IBgAFBVV95cUxOeXpLMkVMZk1XdnVDVVkwa194SGRUQXNvdTNVSW0wRHJONVpSblFUR0MzMHVHanh6U2k5V2FpMm80cnhFOWk2RHpPR3dxQWNGSmlYeHlRSEtQUElKcXl6UUNIVlYwb0RYWUJpNGJ5c1JQcmZPUXJkbVZhM1lON0FrcA?oc=5\" target=\"_blank\">Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMipgFBVV95cUxQX0FwZUFLdlI4aXh3YzlkVXQ1ZU9RTTFPVjJkRkdfeWZBSGh0SGxiVzMyS3ByRThQelRVLTBaUUZ2dVd3MS0tWmtmYVVkVGxkWHZfOWVjY0pDSmliQjN2cllBNlhfU2hiRkJ2SHBJLWZIazloOUtfdEQ1UlJKT0dObDdnYUpyNjVobDVRNTZiXzN1ZFZWblozUElpaU9rSHZoY09oS253?oc=5\" target=\"_blank\">Novartis Agrees to Acquire Avidity Biosciences for $12 Billion<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi-gFBVV95cUxQUklDSldubVVxVjFZQkRGcmxIYzZrRW1PdVd0LUlUUkRsMkotUHRBRUVPUXdLc2Vxb1hmbndNTXhOam9Eei0yb08xMGpHYU9tRWlxaFJQYW4wcjUxUnZVdjVIRy1UYVUwcXlWcjFIdHVHemRscE0yZnVaVU1nWEU0aXFYZnVZX2xLT1VNN1licWppZ0oyOWE2NXAwNllBQXBwMVV1N3ctYXBJOFBqYkg5OUxOejRXcG1tY1FqUy05ZkE0cmp4clBrTFZHLV9ZZFlQbXFEVUJ3c3V5MENDVXNJemsxTFJwajNRSHFyTW8zaHBCRTVwbUJmS1dR?oc=5\" target=\"_blank\">Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Novartis<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi5wFBVV95cUxQYnZsSldkcTFNeEJ0YWtPZUlONFpvalBVZzNkMThSWUtMemRlMEswOWNVQ1hFLXN3dlQzOU1DaVNSS21BbEhMNVNHZnFUNl90N0dPLWlMRC1MbjY5VW9XNHh3QlhkajBMamtKMEhmMzRZNDJhTTg2aXNHTmZiWk4yVXZ4aVYzdFc1dGRWNDRpUFA0ejhWbmRha0I3eFhYYWt5bGtCTU9vWmxBV3h0cE0tX3dYQmoyYTZOdDVZRUlkMUViMVdVVGF2SGVJd25zOXE0d0huUnRRaTRsSHpRY1VwQU50RmZ0T0U?oc=5\" target=\"_blank\">Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters<\/font><\/li>\n<\/ol>\n<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiuwFBVV95cUxQVHdwZjZBdkpiT18wdlh4V3FHTEcxVmp4OGJ3cmZfLVhoa015ZjJwTEpEZC1fb09JLTlPVUlBR0ZoVFFWanVmLTNNdVJCR29qUUdEeVFaUlVNS3ZkZEtmeURlZF9FTG5JQkVhLTMzdXRNN0ZYeHFrYllyQkdUa1dNT0pwbFlDRGdmVnNlUjctUVNIV1dGTTdfb1FTWWhweTJiRElJdF9pajJEVDhySEgzZEZXVDlqVVlJTWhN?oc=5\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novartis to acquire Avidity Biosciences for about $12 billion&nbsp;&nbsp;Reuters Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash&nbsp;&nbsp;CNBC Novartis Agrees to Acquire Avidity Biosciences for $12 Billion&nbsp;&nbsp;The Wall Street Journal Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline&nbsp;&nbsp;Novartis Novartis nears deal to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":169538,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-169537","post","type-post","status-publish","format-standard","has-post-thumbnail","category-breaking-news-video","entry"],"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/169537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=169537"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/169537\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media\/169538"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=169537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=169537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=169537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}